Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial
NCT02283346
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Prostatic Neoplasms
Interventions
RADIATION:
HDR brachytherapy + hypofractionated EBRT
Sponsor
AC Camargo Cancer Center